加载中
NASDAQHealthcareBiotechnology
最新数据
US$25.76
+US$0.04 · +0.16%
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
前收盘价
US$25.76
+US$0.04 · +0.16%
盘中时间采用ET。市场数据可能有所延迟。
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
日内区间
当前US$25.76
52周区间
当前US$25.76
盘中时间采用ET。市场数据可能有所延迟。
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
日内区间
当前US$25.76
52周区间
当前US$25.76
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1856.11万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1220.1万0.02%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF676.85万0.01%954亿 USD0.05%US$235+0.80%
State Street SPDR S&P Pharmaceuticals ETFXPH362.47万0.79%4.62亿 USD0.35%US$64.65+1.60%
Vanguard Russell 2000 ETFVTWO341.49万0.02%180亿 USD0.06%US$112.66+0.50%
iShares Russell 2000 Growth ETFIWO295.86万0.02%139.17亿 USD0.24%US$356.78+0.94%
Schwab U.S. Small-Cap ETFSCHA239.13万0.01%218.24亿 USD0.03%US$32.79+0.40%
T. Rowe Price Small-Mid Cap ETFTMSL189.61万0.06%30.87亿 USD0.55%US$41.18+0.59%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFState Street SPDR S&P Pharmaceuticals ETFXPHVanguard Russell 2000 ETFVTWOiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAT. Rowe Price Small-Mid Cap ETFTMSLAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
